Navigation Links
Novartis Oncology Launches GIST Alliance™ for Healthcare Professionals Treating Gastrointestinal Stromal Tumors
Date:1/29/2009

Novartis Oncology is introducing GIST Alliance™, a unique support program with the goal to help healthcare professionals optimize outcomes in KIT-positive GIST patients.

East Hanover, NJ (PRWEB) January 29, 2009 -- Though rare, gastrointestinal stromal tumors (GISTs) are currently the most common mesenchymal tumors of the gastrointestinal tract, with an estimated 3,300 to 6,000 new cases reported each year in the United States (1, 2). Approximately 2,500 of these cases are metastatic at diagnosis (3).

GISTs are soft tissue sarcomas. Sarcomas are difficult to differentiate from other malignancies when they are found within organs; thus, they are frequently misdiagnosed and highly underreported (4).

Novartis Oncology is introducing GIST Alliance™, a unique support program with the goal to help healthcare professionals optimize outcomes in KIT-positive GIST patients.

Novartis Oncology, the global leader in KIT-positive gastrointestinal stromal tumor (KIT+ GIST) therapy, has been working with healthcare professionals and patients worldwide to help improve the treatment of KIT+ GIST. GIST Alliance is a distinctive, integrated program that builds on the support and educational materials that Novartis Oncology has been providing to healthcare professionals and patients/caregivers by offering access to the most current resources.

For healthcare professionals, GIST Alliance provides and facilitates access to:


    Source: PRWeb
    Copyright©2009 Vocus, Inc.
    All rights reserved

    2

    GOOD

    Page: 1 2 3

    Related medicine news :

    1. Novartis Vaccines Launches National Gift-Giving Program to Help Protect Loved Ones by Reserving an Influenza Vaccination
    2. Colorado Influenza and Pneumococcal Alert Coalition (CIPAC) Partners with Novartis Vaccines for Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers
    3. Novartis Vaccines Partners With RediClinic for Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers
    4. Novartis Vaccines to Host Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers
    5. Watson and Novartis Settle Lawsuit Over Exelon(R) Patent Litigation
    6. Novartis and Sony Pictures Television Internationals Latin American Advertising Sales Group Launch Partnership to Create Multi-Media Platform for Breast Cancer Awareness, Detection, and Treatment in Latin America
    7. Emerging Combination Therapies, Including Drugs from Novartis/Schering-Plough and GlaxoSmithKline/Theravance Will Drive the COPD Drug Market to More Than $11 Billion in 2017
    8. Novartis, Pfizer and Merck Take the Lead on Strong Relationships with Physicians, as Doctors Demand an Expanding Set of Services
    9. Novartis Pharmaceuticals Corporation to Appeal Judgment in Alabama Pricing Case
    10. Novartis Makes Accessing Prescription Assistance and Disease Management Programs Simpler and Easier for Patients
    11. Mylan Announces Settlement Agreement with Novartis Related to Femara(R) First- to-File Opportunity

    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/27/2009)... Walking and cycling plus low-emission vehicles ma... , FRIDAY, Nov. 27 (HealthDay News) -- En...d of using cars would offer much greater public he...vehicles, U.K. researchers have found. , The st...of alternative urban land transport scenarios for ...
    (Date:11/27/2009)..., Voyant Health™ an...Michigan) has licensed its TraumaCad Enterprise or...end workflow solution. , ...announced today that Spectrum Health (Grand Rapids...orthopedic templating solution and its TraumaCad E...
    (Date:11/27/2009)..., Three new interactive a... Williams & Wilkins expand health sciences lea... Durham, NC (Vocus) November...ams & Wilkins (LWW), a division of Wolters Klu...ree new anatomy education apps on the App Store. C...
    (Date:11/26/2009)..., In the next 25 years, the number of Americans l... from 23.7 million in 2009 to 44.1 million in 2034...almost triple, rising from $113 billion to $336 bi...obesity, researchers based at the University of Ch...re . , The number of those with diabetes covered...
    (Date:11/26/2009)... Fans get a bigger thrill when on an emotional rol...v. 26 (HealthDay News) -- Call it the fear factor ...ggests that spectators -- especially those who roo...faction if it,s a closely contested match and vict...even despair. , Chew on that this Thanksgiving ...
    Breaking Medicine News(10 mins):Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3
    ...ies for treating chronic pain , FRIDAY, Nov. 2 (H...xynitrite, a potent oxidant that,s formed when pat...f tolerance to the pain-relieving effects of the n...issue of the Journal of Clinical Investigation , ...
    ...ember 7, 2007, WALTHAM, Mass., Nov. 2 Interleuki... it will release its third quarter,financial resul...s. The,Company,s management will host the conferen...s the live call on November 7, 2007 at 4:30 PM EST...
    ...als, Inc. (NYSE: BRL ) today confirmed that its s...a challenge of the patents listed by,Novartis Phar...alin(R) LA,(methylphenidate hydrochloride) extende...eneric Ritalin LA product with the U.S.,Food & Dru...
    ... Patients Requiring,Dialysis; More Than 700 North...SEGUNDO, Calif. Nov. 2 DaVita, Inc., one,of the n...services in the,United States, announced today its...lly for kidney disease patients,by nearly 50 perce...
    ...sing events to find the cure, CLEVELAND, Nov. 2 ...ed November as Tay-Sachs Awareness Month,and encou...ce of genetic,testing and the need for research to...ish Americans. One in every 250 people,is a carrie...
    ...Dental Clinic Services, HARRISBURG, Pa., Nov. 2 ... announced the award of more than $1.1,million in ...access to,primary medical and dental care in Penns...erships to create or expand,primary care medical a...
    Other Medicine News:Health News:Blocking Potent Oxidant Could Prevent Morphine Tolerance 2Health News:Interleukin Genetics to Host Third Quarter 2007 Financial Results Conference Call November 7 2Health News:Interleukin Genetics to Host Third Quarter 2007 Financial Results Conference Call November 7 3Health News:Barr Confirms Patent Challenge of Ritalin(R) LA 2Health News:Barr Confirms Patent Challenge of Ritalin(R) LA 3Health News:DaVita to Open First Independent Dialysis Clinic in Fargo-Moorhead 2Health News:Governor Strickland Declares November Tay-Sachs Awareness Month 2Health News:Governor Strickland Declares November Tay-Sachs Awareness Month 3Health News:PA Health Department Awards Community Primary Care Challenge Grants 2
    (Date:11/25/2009)..., Nov. 25 ERT (Nasdaq: ...ey, the Company,s President and CEO, and Keith Sch...FO, are scheduled to present at the 21st Annual Pi...on December 1, 2009 in New York City, New York. ,... by visiting the Company,s corporate website at h...
    (Date:11/25/2009)..., Fla., Nov. 25 For many...pecially the 27 million living with untreated hea..., says audiologist Cindy Beyer. ,, Dr. Beyer, s... of America,s largest hearing care and hearing ai...ss to stress, frustration, and social isolation, "...
    (Date:11/25/2009)...China, Nov. 25 /PRNewswire-Asia-FirstCall/ -- Chin...r "the Company") (Nasdaq: CSKI ), a,leading fully...producing,over-the-counter drugs in the People,s R... Company recently passed the Chinese National Inst...ical Products ("ICPBP") examination,for two of its...
    Breaking Medicine Technology:ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 3China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3NBCH Calls for Cost Containment and System Transformation in Health Care Reform Legislation 53878 1NBCH Calls for Cost Containment and System Transformation in Health Care Reform Legislation 53878 2NBCH Calls for Cost Containment and System Transformation in Health Care Reform Legislation 53878 3Cooperation Between Faith Based Organizations and UNFPA Critical to Maternal Health Say Groups 53875 1Cooperation Between Faith Based Organizations and UNFPA Critical to Maternal Health Say Groups 53875 2deCODE genetics Announces Webcast of Conference Call to Discuss Second Quarter 2009 Financial Results 13422 1deCODE genetics Announces Webcast of Conference Call to Discuss Second Quarter 2009 Financial Results 13422 2
    ...tients, LOUISVILLE, Ky., Sept. 29 Potentia Pharm... developing medicines for the treatment,of age-rel...at the,Company,s leading drug candidate, POT-4, ha... I study. POT-4 is a complement inhibitor, which s...ould otherwise lead to local,inflammation, tissue ...
    ...o improve healthcare,system in the Democratic Repu...n Global,Initiative recognized BD (Becton, Dickins...dical technology company, for its commitment to th...ne system monitoring and,healthcare worker safety ...search Center in the Democratic Republic of the Co...
    Other Medicine Technology:Potentia Pharmaceuticals Announces Positive Safety Data and Study Expansion in Phase I Trial for Lead Drug Candidate POT-4 2Clinton Global Initiative Announces BD's Commitment to Biamba Marie Mutombo Hospital 2Clinton Global Initiative Announces BD's Commitment to Biamba Marie Mutombo Hospital 3
    ...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
    ...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
    ...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
    ...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
    Medicine Products: